Clinical Trial

Relation Between Lymphocyte-to-C-Reactive Protein Ratio and Coronary Artery Disease Complexity

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2025 (before its estimated December 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
Aim(s) of the Research : 1. To assess the relationship between the lymphocyte-to-CRP ratio and CAD complexity as assessed by Syntax score in both emergency (STEMI patients undergoing PPCI) and elective settings (patients undergoing scheduled CA plus PCI). 2. To test the relation between the LCR ratio and short-term major adverse cardiac events (MACE) within 6 months duration in patient undergoing primary PCI.
Trial Details
NCT Number NCT06958562
Lead Sponsor Assiut University
Conditions Coronary Artery Disease
Enrollment 600 participants
Start Date 2025-06-03
Primary Completion 2025-12-10 (estimated)
Study Completion 2026-04-10 (estimated)
Updated on ClinicalTrials.gov 2025-05-06